The Nasdaq Biotechnology Index fell by 1.21%. Among the constituent stocks, Taysha Gene rose by 24.23%, Lexeo Therapeutics rose by 19.85%, and Blueprint Medicines Corp. rose by 10.89%. In contrast, Amicus Therapeutics (FOLD) fell by 13.02%, Phathom Pharma fell by 21.68%, and Arvinas fell by 24.84%

The Nasdaq Biotechnology Index closed down 1.21%. Component stock Taysha Gene rose 24.23%, Lexeo Therapeutics increased by 19.85%, and Blueprint Medicines Corp. was up 10.89%, ranking third. Aimmune Therapeutics (FOLD) closed down 13.02%, ranking third from the bottom, Phathom Pharma fell 21.68%, and Arvinas dropped 24.84%

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.